142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

A Clinical Approach to Condition Diagnosing using the JuxtopiaŽ Imhotep Open-Wear Platform

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 12:50 PM - 1:10 PM

Yolandra Hancock, MD, MPH , Founder and Executive Director, Delta Health and Wellness Consulting, LCC, JuxtopiaŽ Imhotep Medical Advisor, Mitchellville, MD
Dr. Yolandra Hancock will discuss a collaborative online approach to characterize biomarkers that uniquely identify various health conditions as well as vital signs. During her presentation, Dr. Hancock will also present how wearables, derived from the Juxtopia® Imhotep Open-Wear Platform, may non-invasively diagnose various illness, injuries, and disease away from traditional healthcare environments while also collecting comprehensive healthcare data from populations to improve their healthcare, overall.

Learning Areas:

Communication and informatics

Learning Objectives:
Define biomarkers that uniquely identify various conditions. Describe how clinicians may remotely diagnose various conditions using wearable telehealth devices derived from the JuxtopiaŽ Imhotep Open-Wear Platform.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have extensive experience as a community pediatrician and public health professional working in the areas of child health and childhood obesity prevention and intervention development. I have worked in impoverished areas for the entirety of my career as a physician and have focused on tackling health disparities in the pediatric population, both in terms of direct patient care and in regards to teaching public health and medical students as well as training pediatric residents.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.